Clearbridge Health Statistics

Total Valuation

SGXC:1H3 has a market cap or net worth of SGD 6.51 million. The enterprise value is 9.69 million.

Market Cap	6.51M
Enterprise Value	9.69M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

SGXC:1H3 has 2.17 billion shares outstanding. The number of shares has increased by 11.07% in one year.

Current Share Class	2.17B
Shares Outstanding	2.17B
Shares Change (YoY)	+11.07%
Shares Change (QoQ)	+10.96%
Owned by Insiders (%)	47.71%
Owned by Institutions (%)	4.10%
Float	507.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.66
PB Ratio	0.59
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.69
EV / Sales	0.98
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.57

Financial Position

The company has a current ratio of 0.87, with a Debt / Equity ratio of 0.56.

Current Ratio	0.87
Quick Ratio	0.76
Debt / Equity	0.56
Debt / EBITDA	n/a
Debt / FCF	-2.94
Interest Coverage	-5.86

Financial Efficiency

Return on equity (ROE) is -34.63% and return on invested capital (ROIC) is -12.98%.

Return on Equity (ROE)	-34.63%
Return on Assets (ROA)	-10.99%
Return on Invested Capital (ROIC)	-12.98%
Return on Capital Employed (ROCE)	-32.98%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	121
Asset Turnover	0.44
Inventory Turnover	14.72

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -70.00% in the last 52 weeks. The beta is 0.50, so SGXC:1H3's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	-70.00%
50-Day Moving Average	0.00
200-Day Moving Average	0.01
Relative Strength Index (RSI)	41.65
Average Volume (20 Days)	6,947,385

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SGXC:1H3 had revenue of SGD 9.90 million and -3.61 million in losses. Loss per share was -0.01.

Revenue	9.90M
Gross Profit	4.74M
Operating Income	-3.97M
Pretax Income	-4.14M
Net Income	-3.61M
EBITDA	-3.67M
EBIT	-3.97M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 4.89 million in cash and 6.24 million in debt, giving a net cash position of -1.35 million or -0.00 per share.

Cash & Cash Equivalents	4.89M
Total Debt	6.24M
Net Cash	-1.35M
Net Cash Per Share	-0.00
Equity (Book Value)	11.05M
Book Value Per Share	0.00
Working Capital	-1.20M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.98 million and capital expenditures -140,000, giving a free cash flow of -2.12 million.

Operating Cash Flow	-1.98M
Capital Expenditures	-140,000
Free Cash Flow	-2.12M
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 47.88%, with operating and profit margins of -40.07% and -36.43%.

Gross Margin	47.88%
Operating Margin	-40.07%
Pretax Margin	-41.86%
Profit Margin	-36.43%
EBITDA Margin	-37.05%
EBIT Margin	-40.07%
FCF Margin	n/a

Dividends & Yields

SGXC:1H3 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.07%
Shareholder Yield	-11.07%
Earnings Yield	-55.46%
FCF Yield	-32.57%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SGXC:1H3 has an Altman Z-Score of -5.73. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.73
Piotroski F-Score	n/a